Lilly’s antibody treatment ineffective on patients hospitalized with advanced COVID; Study: Nurses at high risk of contracting coronavirus; CDC to launch V-SAFE to monitor real-time health developments after COVID vaccine distribution.
UnitedHealthcare to provide 200,000 kits including Tamiflu to at-risk patients; AstraZeneca, Oxford COVID-19 vaccine produces similar immune response in older and younger adults; Many pharmacies not giving flu vaccine to children three and younger.
2020 Health Influencer 50 unveiled; FDA approves remdesivir as first drug to treat COVID-19; WHO grants Wikipedia free use of information.
Final stage for Moderna’s COVID vaccine trial is fully enrolled; 29 out of 40 drugs used to treat coronavirus are in short supply; MM+M Media Summit is Nov. 12.
Purdue Pharma pleads guilty; CDC: 300,000 more people died in the U.S. from January-October than recent years; Arthritis drug shows inconsistent results in treating COVID-19.
CA, NY to review any federally approved COVID-19 vaccine; AstraZeneca coronavirus vaccine trial expected to resume soon; Lyra Health partners with meditation app Calm.
Only 58% of Americans say they are likely to get a COVID-19 vaccine; CDC mandate strongly recommends mask wearing when traveling; UNICEF is buying and distributing more than half a billion single-dose syringes to prep for eventual COVID-19 vaccine.
More than 25% of state legislators have accepted campaign contributions from pharma since 2019; Pfizer won’t seek emergency authorization of COVID vaccine until late Nov.; Study: Remdesivir failed to prevent deaths from virus.
Ebola therapy approved by FDA for first time; Oxford scientists develop COVID-19 test that detects virus in five minutes; WHO: Lockdown should be last resort for handling COVID-19 outbreaks.
Pfizer expands COVID-19 vaccine to include children; States oppose Purdue Pharma negotiations; WHO: Health workers, frontline workers, elderly to receive coronavirus vaccine first.
J&J and Eli Lilly pause COVID-19 vaccine studies; Facebook bans anti-vaccination ads; Nevada man first to contract coronavirus twice.
Global supply of Gilead’s remdesivir available by end of Oct.; Lilly, Bill & Melinda Gates Foundation supply coronavirus treatments to low-income countries; MM+M Media Summit takes place Nov. 12.
Lilly’s antibody treatment reduces COVID-19 levels in patients; Nevada orders nursing homes to stop using two rapid coronavirus tests; MM+M Awards winners.
Lilly’s COVID-19 antibody treatment submitted to FDA; Coronavirus patients have heightened risk for developing blood clots; 2020 MM+M Awards take place today.
Moderna slows down COVID-19 vaccine enrollment; Amgen’s cancer tumor treatment has positive effect on tumor shrinkage; Webcast: How connected is your labeling management?
